- Advertisement -
The DEA begins reviewing its proposal to move cannabis to Schedule III, even as reform advocates criticize their exclusion from the hearing process.
getty
The Drug Enforcement Administration kicks off its hearing on a proposal to reclassify recreational cannabis under federal drug laws. The DEA rescheduled medical cannabis in FDA-approved drugs and from state-licensed operators in April, marking the most significant change in U.S. cannabis policy in half a century.
The DEA hearing, which is…
